Stocktoria
INTENSITY THERAPEUTICS, INC. INTS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-06-30
INTENSITY THERAPEUTICS, INC. statistics & valuation
Market cap$11.1M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -82.3% | -340.1% | -60.9% | -431.5% |
| Return on equity | -97.7% | -557.5% | -80.1% | 50.2% |
| Current ratio | 5.92 | 1.92 | 3.91 | 0.21 |
Source: SEC EDGAR filings · CIK 0001567264 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.